19 March 2019, 19 Member States are to evaluate 100 substances over the next three years. For the 31 substances specified for 2019, the evaluating authorities have 12 months from today to carry out their evaluations.
The main purpose of the evaluation is to clarify whether further information is needed to conclude whether a substance poses a risk to humans or the environment. If necessary, the registrant will be required to provide this information. Authorities will assess suspicious issues and initiate regulatory risk management actions where relevant.
ECHA encourages registrants of listed substances to coordinate their actions and liaise with evaluating member states. Registrants are also urged to update their profiles, especially for purposes and risks. They will have the opportunity to comment before any decision to request further information. The evaluating authorities draft decision will be reviewed by other member states and the ECHA before a final decision is made.
These substances are assessed on the basis of problems associated with their severe hazard characteristics. The substances may be suspected sensitisers, persistent, bioaccumulative and toxic (PBT) substances, carcinogenic, mutagenic and reprotoxic (CMR) substances or endocrine disruptors. The selection also considers wide dispersive worker or consumer use. The evaluation may also result in the identification of other concerns on the substances.